Recent Headlines
Within Pharmaceuticals
Affinity Biologicals, a Manufacturer of Thrombosis and Hemostasis Research Products, Announces Involvement in the ISTH SSC 2016 Meeting
The 62nd Annual Meeting of the Scientific and Standardization Committee (SSC) of the International Society of Thrombosis and Hemostasis (ISTH) begins on May 25th in Montpelier, France, and will continue through to the 28th. Affinity Biologicals will participate in the event through a discussion of products with clients and networking with other researchers in the field. - May 14, 2016 - Affinity Biologicals
Lysosomal Storage Disorder - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Lysosomal Storage Disorder - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. - May 14, 2016 - DelveInsight
New Rule Helps Public Health Agencies Track and Prevent Workplace Injury and Illness
Nearly 5,000 workers die each year and millions are injured on the job in the U.S., costing roughly $250 billion per year. This amount is more than the cost of many other common diseases. The federal Occupational Safety and Health Administration (OSHA) yesterday released a new rule requiring employers to electronically report to OSHA all work-related injuries and illnesses. This new rule will significantly improve the capacity for states to track and prevent work-related injuries and illnesses. - May 12, 2016 - Council of State and Territorial Epidemiologists
The CSE’s Sustainability Academy Leads the Way in Certified Specialized Sustainability (CSR) Education
Affordable, online education and coaching to transform society and the environment. - May 12, 2016 - Centre for Sustainability and Excellence
South Korean Ambassador Tours Start-Up Businesses at HCDC with Congressman Steve Chabot
The purpose of the visit was to present the Ambassador examples of American business, from start-up size such as those he visited at HCDC like GeckoTek, Resolution Air, General Nano, and Sense Diagnostics, to multi-national corporations like Kroger, Fifth Third Bank and Procter & Gamble. - May 12, 2016 - HCDC, Inc.
National Brain Tumor Society Statement on Revised World Health Organization Classification of Tumors of the Central Nervous System
National Brain Tumor Society (NBTS), the largest nonprofit organization in the U.S. dedicated to the brain tumor community, today released the following statement from David F. Arons, Chief Executive Officer, on the publishing of the 2016 updated World Health Organization (WHO) Classification of... - May 12, 2016 - National Brain Tumor Society
Anticoagulants-Market Insights & Drugs Sales Forecast (VTE & AF)-2020 - A DelveInsight Report
According to DelveInsight researchers, the Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 2020 growing at a CAGR of 8.59% from 2015 to 2020. - May 12, 2016 - DelveInsight
Careington Attends Transatlantic Business Conference
Careington International Corporation CEO Barbara Williams will be attending the British American Business Council (BABC) annual Transatlantic Business Conference in London on May 11 and 12, 2016. Attending with Williams will be Bruce Bernstein, Assistant Vice President of Global Sales Development with Careington’s UK affiliate Munroe Sutton, and Head of Munroe Sutton’s Business Development division, Robert Malvasi. - May 11, 2016 - Careington
Bioo Scientific Launches Rapid Strip Test for Detection of Total Aflatoxin in Grain, Nuts and Seeds
Bioo Scientific recently released the MycoFlow™ Total Aflatoxin Strip Test Kit for the rapid detection of total aflatoxin in matrices including corn products, grains, soy, and nuts. This strip test kit features a detection limit of 20 ppb and a fast 5 minute protocol. - May 11, 2016 - Bioo Scientific
Obsessive Compulsive Disorder (OCD) - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Obsessive Compulsive Disorder (OCD) - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up to date information of market till date order has been placed. - May 11, 2016 - DelveInsight
Makers Nutrition Launches Stock Softgels Brand
Nutraceutical Company Powers Softgel Products to Vitamin and Supplement Businesses - May 10, 2016 - Makers Nutrition, LLC
Europital Will be Present at Knowledge for Growth 2016
Europital will participate for second consecutive time in the “Knowledge for Growth” event that takes place every year at the ICC Building in Ghent, Belgium. - May 08, 2016 - Europital BVBA
MR Solutions to Display Cryogen-Free MRI Imaging Systems at ISMRM in Singapore
MR Solutions will be displaying its latest ground-breaking preclinical cryogen-free MRI imaging systems at ISMRM in Singapore from May 7 to 13. This includes details of a new 9.4T cryogen-free scanner and a compact 3T system with a 12cm bore which are coming soon. All of MR Solutions’... - May 08, 2016 - MR Solutions
Zifo Technologies Rebrands as Zifo RnD Solutions Globally
Zifo Technologies has announced that it has adopted a new brand name of “Zifo RnD Solutions” from May 1, 2016 for its offerings in the R&D space. Zifo RnD Solutions offerings will span across Discovery Informatics, Lab Automation, Clinical Services, Translational Research and the Genomics Space. - May 07, 2016 - Zifo
Jivana Biotechnology Inc Adds Dr David Jablons to Its Advisory Committee
Dr David Jablons Brings Thoracic Surgical Oncology and Lung Cancer Drug Development Experience to The Jivana Advisory Committee. - May 06, 2016 - Jivana Biotechnology Inc
3097 Pounds Shed by Minnesotans in the Slim Down Challenge; Winners Announced
The Slim Down Challenge, hosted by Seattle Sutton’s Healthy Eating (SSHE) of Minnesota, was a 16-week challenge for participants to improve their health and lose weight through their nutrition. Over 300 Minnesotans entered the Challenge, with 81 of them completing the full 16-week period, losing a total of 3097 pounds, and achieving substantial improvements in their health metrics as a result. - May 05, 2016 - Seattle Sutton's Healthy Eating
The Morgan Leary Vaughan Fund Honors Dr. Edmund F. La Gamma
The Morgan Leary Vaughan Fund honored Edmund F. La Gamma, MD, Chief, Newborn Medicine at Maria Fareri Children's Hospital, a Member of the Westchester Medical Center Health Network, with the inaugural Lily Pedro Award for Excellence. The event, The 1st Annual Morgan's FunDay, was held at the... - May 05, 2016 - The Morgan Leary Vaughan Fund, Inc.
RuCor Strategies LLC Announces the Launch of CamCare, the First National Membership Benefit Reimbursement Program for Complementary Alternative Medicine Services
Designed membership plans help consumers pay for complementary alternative medicine visits. - May 04, 2016 - RucorStrategies, LLC / Camcare
NJHA Brings Medication Risk Mitigation Services to New Jersey Hospitals Through Strategic Alliance with Tabula Rasa HealthCare
New Jersey Hospital Association and Tabula Rasa HealthCare (TRHC) have entered into a 3-year agreement to offer TRHC's proprietary Medication Risk Mitigation™ products and services to NJHA’s nearly 400 member healthcare organizations. - May 02, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare Names Kristen Propp Creative Director; Healthcare Technology Company Expands Marketing Heft with New Hire
Tabula Rasa HealthCare, Inc. (TRHC) President Orsula V. Knowlton announced graphic designer, Kristen Propp, has joined the healthcare technology company as Creative Director. TRHC is a leader in providing patient-specific, data-driven technology and solutions for health care organizations. - May 02, 2016 - Tabula Rasa HealthCare
Pediatric Brain Tumor Foundation's New Campaign Aims to Raise Awareness in May and Every Day
The Pediatric Brain Tumor Foundation believes the conversation about brain tumors is bigger than just one month. That’s why the world's largest nonprofit funder of childhood brain tumor research is kicking off Brain Tumor Awareness Month with the “May and Every Day” campaign. - May 02, 2016 - Pediatric Brain Tumor Foundation
Sentnyl Therapeutics, Inc. Re-Launches Abstral® in the United States
Sentynl Therapeutics, Inc. (“Sentynl”) announced that its commercial organization relaunched Abstral® in the United States. Sentynl acquired the rights to market Abstral® from Galena Biopharma in November 2015. Abstral® is indicated for the management of breakthrough pain... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Acquires Abstral®
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it acquired the rights to market Abstral® in the U.S. from Galena Biopharma. Abstral® is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are... - May 01, 2016 - Sentynl Therapeutics, Inc.
Europital Launches Its New Website
Europital has officially launched its new website, a new and completely renovated concept to improve users experience, simplify navigation and facilitate visitors’ ability to access company’s relevant information. - May 01, 2016 - Europital BVBA
Sentynl Therapeutics, Inc. Launches Sentynl Patient Services
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it launched Sentynl Patient Services to enhance patient access to its products. Sentynl Patient Services provides support to patients who want assistance with investigating their benefits, affording their medications and locating... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Welcomes Darren Pincus as Vice President of Business Development
Sentynl Therapeutics, Inc. (“Sentynl”) announced that Darren Pincus joined Sentynl as its Vice President and head of Business Development. Mr. Pincus is a highly experienced business development professional with a strong track record of successfully completed transactions. Prior to... - May 01, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Launches Its Commercial Organization
Sentynl Therapeutics, Inc. (“Sentynl”) announced that it launched its commercial organization including a full-time, professional sales force of key account specialists. About Sentynl Therapeutics. Sentynl provides healthcare professionals with treatment solutions that enable them to... - April 30, 2016 - Sentynl Therapeutics, Inc.
Sentynl Therapeutics, Inc. Welcomes Michael Hercz as Its Senior Vice President and General Counsel
Sentynl Therapeutics, Inc. (“Sentynl”) announced that Michael Hercz joined Sentynl as its Senior Vice President, General Counsel and Chief Compliance Officer. Mr. Hercz brings more than 18 years of legal, compliance and risk management experience to Sentynl. Prior to Sentynl, Mr. Hercz... - April 30, 2016 - Sentynl Therapeutics, Inc.
IQ4I Research & Consultancy Published a New Report on “Immune Checkpoint Therapeutics – Hot Targets & Pipeline Analysis”
The pipeline analysis focuses on novel medicines covering small molecules, monoclonal antibodies, Recombinant proteins, Bi-specific Ab’s, Antibody drug conjugates, Cell therapy, Peptides, Oncolytic viruses and Vaccines. The report also covers hot targets in research for Checkpoint modulators. - April 28, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Pediatric Brain Tumor Foundation Introduces Free Toolkit for Newly Diagnosed Families
The Pediatric Brain Tumor Foundation is pleased to announce the publication of the Star Portfolio, a new resource for families of children recently diagnosed with a brain tumor. “Our new Star Portfolio is a toolkit designed to help families of newly diagnosed brain tumor patients partner... - April 28, 2016 - Pediatric Brain Tumor Foundation
Compounding Pharmacy Supplies Medication for Study Using Edetate Disodium Therapy
Following the generally positive outcome of the National Institutes of Health-funded Trial to Assess Chelation Therapy (TACT)[1] study completed in 2012, it was decided that further research was warranted to test the safety and effectiveness of Chelation therapy as a treatment option for... - April 27, 2016 - Universal Arts Compounding Pharmacy
ALPCO’s Bioactive Leptin ELISA Allows Researchers to Differentiate Between Leptin Resistance and Non-functional Leptin
ALPCO recently announced the release of its Bioactive Leptin ELISA, offering diabetes and obesity researchers a new tool to differentiate between leptin resistance and non-functional leptin. The assay allows for the measurement of leptin in human serum through the process of binding leptin to... - April 26, 2016 - ALPCO
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study - The Reanima Project - Is Death Reversible? - April 25, 2016 - Bioquark Inc.
CRO Analytics and ACRP Unveil Site Voice™ Advisory Board Members
Site Voice findings and Board Members were announced during the ACRP Executive Summit on Site Strategies. - April 23, 2016 - CRO Analytics
MR Solutions Wins Queen’s Award for Enterprise
MR Solutions, of Guildford has won the prestigious Queen’s Award for Enterprise in the innovation category. This award is announced on the Queen’s birthday, 21 April and is one of the UK’s highest accolades recognising business achievement. This has been achieved in recognition... - April 23, 2016 - MR Solutions
Fahad Al Tamimi to Host a Special Dinner in Support of Research Into Radiation Therapy
Fahad Al Tamimi will welcome high profile guests in London next week to support further research into the area of radiation therapy. - April 22, 2016 - Fahad Al Tamimi Philanthropy
Morgan's Fund Issues Statement on Selection for NORD's Natural History Studies Project
A statement was issued today by Stephanie M. Vaughan, Co-founder and President of The Morgan Leary Vaughan Fund (Morgan’s Fund), regarding the announcement of the National Organization for Rare Disorders’ (NORD) selection of Natural History Studies Project participants. - April 22, 2016 - The Morgan Leary Vaughan Fund, Inc.
ValueCentric’s Order Management Module Becomes Choice Solution for Top Pharma Manufacturers
ValueCentric, the industry leader in healthcare channel intelligence, announced today that their Order Management application surpassed a significant milestone of $200 billion in processed orders annually. Following two recent implementations, the company is now processing critical order data for... - April 22, 2016 - ValueCentric
San Diego Intellectual Property Management and Consulting Firm Established by Seasoned Patent Agent
WALLACH IP Management and Consulting announced a new business venture focused on professional patent protection services. Founder Dr. Brenda Wallach, who has nearly twenty years' experience advising cutting-edge companies, is filling a critical need for companies that must protect their intellectual property and do so at a reasonable cost. The firm specializes in the areas of biotechnology, pharmaceuticals, therapeutics, renewable biofuels and medical devices. - April 21, 2016 - WALLACH IP Management and Consulting
Nanohybrids Expands Nanoparticle Product Line with Launch of 30 nm Gold Nanospheres
NanoHybrids releases 30 nm spherical gold nanoparticles. With this product launch NanoHybrids now offers a full complement of NanoSphere products ranging in diameter from 5 nm to 60 nm. Various surface coatings are also available to suit a wide range of application needs. - April 20, 2016 - NanoHybrids
MartinCSI Earns Control System Integrators Association's Certification for the Fifth Consecutive Time
MartinCSI announces their completion of the Control Systems Integrators Association (CSIA) “Best Practices and Benchmarks” recertification. This is the fifth consecutive time MartinCSI has passed the CSIA Certification audit process. The Control System Integrators Association is a... - April 17, 2016 - MartinCSI
Jivana Biotechnology Inc Announces Additions to Its Advisory Committee
Jivana Biotechnology adds Patrick Sage and Dr Frank Facchini to its advisory committee. - April 16, 2016 - Jivana Biotechnology Inc
Montana Molecular Appoints MoBiTec, Germany, as Distributor to Sell Genetically Encoded Fluorescent Biosensors
While fluorescent dye-based assays are powerful tools for high-throughput screening in engineered cell lines or cell lysates to show that signaling has occurred, genetically encoded sensors that measure dynamic processes in physiologically relevant cells provide a higher level of insight into how signals are regulated in both space and time. It is the regulation of signaling that controls cell function in both health and disease. - April 16, 2016 - MoBiTec GmbH
ImaBiotech Signs License Agreement with Lawrence Berkeley National Laboratory
ImaBiotech, a CRO company developing and offering mass spectrometry imaging (MSI) services, applications, and software, announces today a license agreement with Lawrence Berkeley National Laboratory (Berkeley Lab) to “OpenMSI” intellectual property to support ImaBiotech... - April 16, 2016 - Imabiotech
Hypoxia Inducible Factor (HIF) Inhibitors - Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report Hypoxia Inducible Factor (HIF) Inhibitors - Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this their research expertise provides their clients with up to date information of market till date order has been placed. - April 16, 2016 - DelveInsight
Arteric Appoints New Director of Technology Fast-Growing Pharmaceutical and Biotechnology Digital Agency Broadens Its Digital Healthcare Capabilities with 15-Year Veteran
Arteric is pleased to announce that Jon Fisher has joined Arteric as its new Director of Technology. Jon has worked in technology and digital marketing for 15 years and has spent the past 9 years working in a healthcare marketing agency. - April 15, 2016 - Arteric
The New York Center for Nanomedicine Research, Inc. is Signing a Strategic Agreement to Provide Drug Delivery Systems to ICAHRIS in Canada
Strategic agreement for the development of nanoparticules with application in Cancer, Type 2 diabetes and inflammation. The NYCNMR is providing to ICAHRIS, its innovative platform dedicated to Nanomedicine. The NY center is located in the upcoming Bio-Cluster located in Buffalo NY. - April 14, 2016 - New York Center for Nanomedicine Research, Inc.
BreviTest Awarded Grant from National Institute on Drug Abuse to Optimize Device for Rapid Cannabis Testing
BreviTest Technologies has been awarded a $234,412 grant from the National Institute on Drug Abuse of the National Institutes of Health (NIH) to explore rapid testing for THC, the main active ingredient in cannabis. The federal funds, awarded under the NIH’s Small Business Innovation Research... - April 14, 2016 - Cayman Chemical Company
Cesar Chavez Lifetime Achievement Award Given to North County Health Services’ CEO
The network of 11 clinics has become a medical home for over 62,000 patients and clients for nearly two decades. - April 13, 2016 - NCHS
Pancreatic Cancer – Market Insights, Epidemiology and Market Forecast-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for... - April 13, 2016 - DelveInsight